According to FutureWise analysis the market for enoxaparin sodium in 2023 is US$ 3.7 billion, and is expected to reach US$ 7.09 billion by 2031 at a CAGR of 8.47%.
The drug enoxaparin sodium (blood thinner) is an anticoagulant heparin with a low molecular weight. The drug is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as blood clots during pregnancy and after certain types of surgery. In pulmonary embolisms, blood clots become trapped in lungs' blood vessels and cause the lungs to collapse. In addition to knee and hip replacement surgery, it may also be prescribed following abdominal surgery and during major illness. Furthermore, enoxaparin sodium is used in people who have acute coronary syndrome (ACS) or heart attacks. An injection is given into a vein or just under the skin. There are many adverse effects associated with this drug, such as bleeding, fever, and leg swelling. An individual who has a spinal tap might experience bleeding. It prevents and treats deep vein thrombosis (DVT) and pulmonary embolism (PE), including during pregnancy and after surgery. The drug is also used in the treatment of acute coronary syndromes (ACS) and heart attacks. A vein or just under the skin is injected with the drug. The drug is also used during hemodialysis.
The most common side effects are bleeding, fever, and leg swelling. There is a risk of serious bleeding during a spinal tap, especially in those who are undergoing the procedure. The baby appears to be safe when used during pregnancy. In the family of medications called low molecular weight heparins, enoxaparin belongs. As an essential medicine, enoxaparin is available as a generic and under several brand names. It is a heparin-based drug. As the prevalence of heart disease rises along with cases of deep vein thrombosis and pulmonary embolism, enoxaparin sodium market growth will accelerate. Market growth is boosted by the increasing number of surgeries and the need to prevent complications. There are several factors which boost the growth of the market, including an increase in the number of FDA-approved drugs and an increase in the geriatric population. Market growth is fueled by increased awareness for the treatment of several cardiovascular diseases. In addition, growth in healthcare expenditures, increase in research and development activities by pharmaceutical companies, and the launch of novel drugs in the market contribute to the growth of the enoxaparin sodium market. The side effects associated with enoxaparin sodium and the availability of alternative drugs are expected to hamper the growth of the enoxaparin sodium market.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Enoxaparin Sodium Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Enoxaparin Sodium Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.